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ABSTRACT

Neurodegeneration, a progressive loss of nerve cells (neurons), occurs in many neurological
disorders including Alzheimer’s disease, Parkinson’s disease, Schizophrenia, and drug addiction.
Cytoskeletal disruption in neurons and aggregation of proteins associated with these disorders is
the hallmark of neurodegeneration. However, the cause of neurodegenerative disorders is
unknown and currently there are no effective drug treatments. Aging is the most consistent risk
factor for developing a neurodegenerative disorder, and recent evidence suggests that
environmental factors, which act as endocrine disruptors, pose a risk in the disease process. 4nonylphenol (4-NP), an endocrine-disrupting compound (EDC), has been shown to affect brain
development and may cause neurodegeneration. In the environment, 4-NP arises as a degradation
product of alkylphenol polyethoxylates, compounds widely used as nonionic surfactants in
commercial production, as well as in herbicides, pesticides, polystyrene plastics, and paints and
has been shown to undergo high level of accumulation in biological tissues. However, the
mechanism by which 4-NP exerts its effect is not understood. Recent results from our laboratory
indicate that Gβγ, an important component of the G protein-signaling pathway, induces neurite
outgrowth and that the interactions of Gβγ with microtubules (MTs), an important component of
the cytoskeleton, is important for this process. Furthermore, we found that blocking the Gβγ-MT
interaction induces neurodegeneration. The goal of the present research is to determine whether
4-NP inhibits neurite outgrowth and induces neurodegeneration by altering the Gβγ-MTmediated pathway, and if other cytoskeletal components are involved in this process.
Pheochromocytoma (PC12) cells were used to conduct the study because they respond to nerve
growth factor (NGF) and exhibit a typical phenotype of neurons. In Specific Aim 1, using
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biochemical, pharmacological, and immunoconfocal methodologies, I have demonstrated that 4NP inhibits neurite outgrowth and induces neurodegeneration by altering MT-Gβγ interaction in
PC12 cells. In Specific Aim 2, I have conducted the proteomic analysis of 4-NP treated cells and
found that the compound affects the cytoskeletal profile in NGF-differentiated PC12 cells. In
conclusion, I propose that one of the mechanisms by which 4-NP causes neuronal damage is by
altering the Gβγ-cytoskeletal mediated pathway, which is critical for neuronal growth and
development.
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CHAPTER 1: INTRODUCTION

1.1. 4-Nolylphenol (4-NP)

There are established and increasing concerns of the potential health hazards caused by
endocrine-disrupting compounds (EDCs), which are found in foods, pesticides, industrial
chemicals, and consumer products. EDCs have adverse effects on wildlife, human health, and the
environment. These compounds also play a role in disturbing homeostatic control and contribute
to psychological disorders, cancer, and defects in reproductive, behavioral, and immune
functions (Safe, 2000). 4-Nolylphenol (4-NP), one of the most prevalent EDC, is a synthetic
organic chemical produced in relatively large quantities in the U.S. and used primarily in making
detergents, pesticides, plastics, and rubber, as well as other commercial uses. Human exposure to
4-NP may occur through ingestion of contaminated foods, drinking water, and contact with
detergents. 4-NP is an anaerobic breakdown product of nonylphenol ethoxylates (NPEOs),
mixtures of non-ionic surfactants that are used in industrial and institutional cleaners, agricultural
pesticides, and paint production (Figure 1.1). 4-NP has been detected in surface and ground
water, sediments, aquatic organisms, wastewater effluent, air, and human food (California
Environmental Protection Agency, 2009; U.S. Environmental Agency, 2010). Recent research
has identified 4-NP as the most significant NPEO degradation product of because of its
estrogenic toxicity, enhanced resistance toward biodegradation, and bioaccumulation in aquatic
organisms (Lin, 2007), with a tissue concentration ranging from 1–20 µM (Bevan et al, 2006).
The most common route of NP entry into the environment is through wastewater.
Because of its extensive use in cleansers, most NPEO are discharged to the sewer system and
make their way into wastewater treatment plants. Under anaerobic conditions such as those
1

found in sewers, sediments, and certain treatment operations at wastewater treatment plants,
NPEO are biodegraded to NP (Porter and Hayden, 2002). Residues of 4-nonylphenol have been
reported in river water, groundwater adjacent to a contaminated river, seawater, tap water,
sediments, and fish tissues [Hu, 2002]. Concentrations of 4-nonylphenol in surface waters are in
the range of 0.11 to 180 micrograms per liter. (Tanghe and Verstraete, 2001). Rudel et al. found
concentrations of NP greater than 1000 µg/L in numerous septic tank samples collected from
Cape Cod, Massachusetts (Rudel et al, 1998).

4-Nonylphenol is hydrophobic, relatively

insoluble in water, and can persist and accumulate in sediments and sludge. (Kim et al, 2005). It
may take months or years to degrade in the environment.
NP is toxic to a wide variety of marine and freshwater vertebrate and invertebrate species
in laboratory setting. Because of its potential environmental toxicity issues, European countries
have restricted or banned the use of NPEO since 1980s (Renner, 1997). Because toxicity and risk
at low concentrations have not been clearly proven, United States allowed its use. However, the
level of risk to humans and the environment posed by 4-NP is currently under considerable
debate by researchers, chemical manufacturers, and regulators. There are no existing regulations
for 4-nonylphenol in drinking water; nor is the compound listed as a candidate for future
regulatory decision-making.

2

[Figure 1.1 Chemical structures of nonylphenol polyethoxylate and nonylphenol (Goto and Ibuki,
2004)]
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1.2 4-Nolylphenol (4-NP) and Neurodegeneration.
4-NP, along with other EDCs, have been shown to induce a deterioration of neural
development, a decrease in memory as well as learning capacity and spatial learning, and
permanently alter hippocampus ultrastructurein in mice (Yoshikawa, 2005). Exposure to the
compound also irreversibly influences monoaminergic neural pathways (Negishi et al, 2004). 4NP been shown to inhibit neurotrophin-dependent neurite outgrowth in cultured embryonic
Xenopus spinal-cord neurons and PC12 cells. Interestingly, the effect of 4-NP was not inhibited
by the nuclear estrogen receptor (ER) antagonist (ICI182, 780), but was inhibited by the Gprotein antagonist, pertussis toxin (Bevan et al, 2006). These data suggest that the effects of 4NP are G-protein dependent and exposure may have a potentially damaging impact during early
neuronal development. Other studies have exhibited that gestational 4-NP exposure can
profoundly alter neurobehavioral development and reproductive development in male offspring
and growth development in fetal rats (Jie et al, 2010). Studies conducted in neural stem cells
suggest that 4-NP might directly cause neurodegeneration (Kudo et al, 2004). Taken together,
these studies suggest that 4-NP can affect brain function, neuronal outgrowth, differentiation and
development, and may cause neurodegeneration (California Environmental Protection Agency,
2009).
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1.3 Neuronal Cytoskeleton, Neurite Outgrowth, and Neurodegeneration
Neurite outgrowth and differentiation is a complex process in which two distinct domains
emerge from the cell body: a long, thin axon that transmits signals and multiple shorter dendrites
that are specialized to receive signals. When fully differentiated through elongation of axon and
dendrites, this morphology allows neurons to achieve precise connectivity between appropriate
sets of neurons, which is fundamental to proper functioning of the nervous system. The
cytoskeleton plays a key role in maintaining the highly asymmetrical shape of neurons that is
characterized by neuronal outgrowth, branching, retraction, and guidance. Assembly and
disassembly of microtubules (a major component of the cytoskeleton) is critical for axon and
dendrite formation as well as for neurite outgrowth. Microtubules (MTs) form dense, parallel
arrays in axons and dendrites that are required for the growth and maintenance of these neurites
(Witte and Bradke; Geraldo and Gordon-Weeks, 2009). Selective stabilization of MTs also
occurs

during

neuronal

differentiation

(Bulinsky

and

Gundersen,

1991).

During

neurodegeneration, the MT assembly and proteins associated with them are severely altered.
Neurodegeneration, a progressive loss of nerve cells (neurons), occurs in many neurological
disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and in the aging brain.
In Alzheimer’s disease, amyloid plaques and neurofibrillary tangles (NFT) comprise the two
major neuropathologic brain alterations. NFT are formed from paired helical filaments (PHF)
consisting of tau, a microtubule-associated protein (MAP). Under normal conditions, tau binds to
MT, stabilizing neuron structure and integrity. In an AD brain, the MT structure is disrupted,
which causes tau to be hyperphosphorylated and not bind to the MTs. Lewy bodies, which are
considered cytopathological markers of Parkinson’s disease (PD), are comprised of tubulins
(subunit protein of MTs) MAP1, and MAP2 (Alonso et al., 2008; Amniai et al., 2008; Gustav et
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al., 2010). Previously, the majority of research and drug-discovery efforts in the area of
neurodegenerative diseases have focused on these pathological markers. Although this research
has significantly advanced our understanding of the pathology of neurodegenerative disorders,
the causes remain largely unknown. Most importantly, there are no effective drugs currently
available to treat these neurodegenerative disorders, suggesting a critical knowledge gap in our
understanding of how the diseases are triggered and then progress. Recent results suggest that
MT assembly is severely compromised in both the AD and PD brains (Cash et al., 2003; Cartelli
et al., 2010; Cartelli et al., 2013). This could play a significant role in triggering early disease
phases, followed by the demise of neurons and neuronal death.

[Figure 2.1 MT assembly and its possible role in neurodegeneration. Irregular organization of the
MT cytoskeleton is known to be a feature of neurodegeneration in Alzheimer’s disease (AD) and
Parkinson’s disease (PD). Since Gβγ is known to have a role in the regulation of MT assembly,
we propose that blocking the interaction of Gβγ with tubulin/MTs by 4-NP will alter MT
organization in neuronal cell models and ultimately lead to neurodegeneration.]
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1.4 Microtubule Assembly (MT) and G-Protein-Mediated Signaling
Previous studies from our laboratory have indicated that MT assembly could be regulated by G
protein-mediated signaling (Roychowdhury and Rasenick, 1997; Roychowdhury et al., 1999;
Roychowdhury et al., 2006; Montoya et al., 2007). G protein-mediated signaling, a major
signaling pathway in neurons consists of three components; G protein-coupled receptors
(GPCRs), G protein, and effector molecules. GPCRs constitute the largest family of
transmembrane receptors and mediate the action of extracellular signals as diverse as light,
odorants, peptide hormones, and neurotransmitters. All GPCRs have significant sequence
resemblance to each other and share a similar topological motif comprised of seven hydrophobic
segments that span the lipid bilayer. G proteins act as signal transducers and transfer signals from
GPCRs to intracellular effector molecules. These effectors include adenylyl cyclase,
phospholipase

C,

phospholipase

A2,

and

several

ion

channels

(Figure

3.1).

[Figure 3.1 Signal Transduction pathway. An agonist binds to a receptor activating the G-protein.
The G-protein subunits (α and β γ) then dissociate and activate their respective effector molecules]
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Current models of G proteins favor a heterotrimeric structure composed of the guaninenucleotide binding α, plus β and γ subunits, the latter two forming a tight association under
nondenaturing conditions. Agonist-bound receptors activate G proteins by allowing GTP to bind
to the βγ subunit of the heterotrimer. Subsequently, activated Gα changes its association with
Gβγ in a manner that allows both subunits to contribute to the regulation of intracellular-effector
molecules (Figure 4.1). The α subunit has an intrinsic GTPase activity, which causes functional
dissociation from the effector and reassociation with βγ. GPCR and heterotrimeric G proteins are
abundant in neurons and involved in regulating neurite outgrowth (Igarashi et al., 1993; Reinoso
et al., 1996; Lotto et al., 1999; He et al., 2005).

[Figure 4.1 G-protein activation cycle. When a ligand activates its receptor, heterotrimeric Gproteins are activated by dissociating into α and βγ subunits through GDP/GTP exchange
mechanism.]
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Evidence from our laboratory indicates that α and βγ subunits of G proteins regulate
microtubule assembly in vitro (Roychowdhury and Rasenick, 1997; Roychowdhury et al., 1999;
Roychowdhury et al., 2006; Montoya et al., 2007). While Gα activates tubulin GTPase and
inhibits

microtubule

assembly,

Gβγ promotes

tubulin

polymerization.

Reconstituted

heterotrimers were shown to be inactive in promoting microtubule assembly, which suggests that
G-protein activation is necessary for the modulation of microtubules by G-protein subunits.
Using the anti-mitotic agent nocodazole, it has been demonstrated that the assembly/disassembly
of MTs alters tubulin-Gβγ interaction in cultured PC12 and NIH3T3 cells (Montoya et al., 2007).
While MT depolymerization by nocodazole inhibited the interactions between tubulin and Gβγ,
this inhibition was reversed when MT assembly was restored by the removal of nocodazole. The
finding suggests that Gβγ might be involved in promoting MT assembly and/or stabilization of
MTs in vivo as demonstrated in vitro. The stimulation of MT assembly in response to GPCR
activation correlated with an increased association of Gβγ with polymerized tubulin, suggesting
that GPCRs may utilize Gβγ to regulate MT assembly in vivo (Gutierrez, Sierra-Fonseca,
Martinez-Jurado et.al, manuscript under preparation).
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1.5 Gβγ-MT Association and Neurodegeneration
More recent studies from our laboratory show that Gβγ is critical for NGF-induced
neuronal differentiation of PC12 cells (Sierra-Fonseca, Martinez-Jurado et.al, Manuscript under
preparation). It was found that NGF-induced neurite outgrowth promoted the interaction of Gβγ
with MTs and stimulated MT assembly. Furthermore, the Gβγ−sequestering peptide GRK2i
inhibited neurite formation, disrupted MTs, and induced axonal damage. Because prenylation
and subsequent methylation/demethylation of γ subunits are required for Gβγ-MTs interaction,
we tested small-molecule inhibitors targeting prenylated-methylated protein methyl esterase
(PMPMEase), and found that these inhibitors disrupted Gβγ and ΜΤ organization, affected
cellular morphology, and inhibited neurite outgrowth. In further support of a Gβγ-MT interaction
role in neuronal differentiation, it was observed that overexpression of Gβγ in PC12 cells
induced neurite outgrowth in the absence of added NGF. Moreover, overexpressed Gβγ
exhibited a pattern of association with MTs similar to that observed in NGF-differentiated cells.
Altogether, results from our laboratory suggested that the G-protein complex Gβγ, initiated by
the activation of the G protein-coupled receptor (GPCR), is a signal-transducing protein
complex, and its interaction with microtubules (MTs) is important to neuronal development,
differentiation, structure, and neurodegeneration (Figure 5.1).
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[Figure 5.1 Gβγ signaling, MT assembly, and Neurite outgrowth. GPCR transduce signals
through heterotrimeric G-proteins. Upon activation, Gα dissociates from Gβγ subunits. Both
subunits then activate signaling pathways such as ion channels, phospholipases, adenylcyclases,
and PI3-kinases. Previous results from our lab have shown that Gβγ stimulates MT assembly,
and induces neurite outgrowth from PC12 cells.
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1.6 Hypothesis and Objective
The objective of my research is to understand the mechanism by which 4-NP, an endocrinedisrupting compound (EDC), induces neurodegeneration. I hypothesize that 4-NP inhibits neurite
outgrowth from PC12 cells and induces neurodegeneration by interfering with Gβγ-MT mediated
pathways. To test this hypothesis, experiments were conducted under two Specific Aims as
described below.
•

Specific Aim-1: Does 4-NP inhibit neurite outgrowth and differentiation, and induce
neurodegeneration by interfering with the MT-Gβγ mediated pathway?

•

Specific Aim-2: Does 4-NP alter the cytoskeleton and associated proteins to induce
neurodegeneration?

These two Specific Aims are important in considering the physiological and toxicological
significance of 4-NP in neurodegeneration.

12

CHAPTER 2: MATERIALS AND METHODS
2.1 Cell Culture, NGF and 4-NP Treatment. PC12 cells (pheochromocytoma cells derived from
the adrenal gland of Rattus norvegicus) (ATCC, Manassas, VA) were grown in 75-cm2 culture
flasks at 37 °C in Dulbecco’s Modified Eagle’s Medium (DMEM) (4.5 g/L glucose, Lglutamine, without pyruvate), supplemented with 10% bovine calf serum and antibiotics (100
U/mL penicillin and 100 µg/mL streptomycin) in 10% CO2. For NGF treatment, PC12 cells were
grown on 100- or 150-mm plates to 70% confluence over 1–2 days. Then, cells were treated with
100 ng/ml of NGF (Sigma-Aldrich, St. Louis, MO) dissolved in complete media for 3
consecutive days. Control cells without NGF were also grown under the same conditions. Cells
were treated with 4-Nonylphenol (sigma-aldrich, St. Louis, MO) at different concentrations
(.2μM, 1μM, 5μM, 10μM and 50μM) for 1 hour. A stock solution of 10 mM 4-NP was prepared
in DMSO and diluted in tissue culture media to a final concentration of 1, 5 or 10 µM 4-NP and
added to the cells as indicated in the figures. The DMSO concentration in the culture media
never exceeded 0.1%. Besides, control experiment was performed in the presence of similar
concentration of DMSO.

2.2 Extraction of Cytoskeletal (CSK) and Soluble Protein (SOL) Fractions. PC12 cells were
grown in 100- or 150-mm plates to 70% confluence over 1–2 days and subjected to NGF
treatment as described above. The plates were used in duplicates for each condition.
Subsequently, the plates were treated with or without 4-NP for 1 hour. Cytoskeletal (CSK) and
soluble (SOL) fractions were prepared by extracting soluble proteins in an MT -stabilizing buffer
(MS). The stabilizing buffer contained 0.1 M PIPES, pH 6.9, 2 M glycerol, 5 mM MgCl 2 , 2 mM
EGTA, 0.5% Triton X-100, protease inhibitor cocktail (Sigma-Aldrich), 0.1 mM GTP, and 1
mM DTT. Briefly, cells were rinsed and incubated with MS buffer (0.5–1 ml) for ~10 minutes at
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room temperature until cells were beginning to lyse. Subsequently, cells were removed
mechanically (using a cell scraper) and centrifuged at 10,000 × g for 10 min. The supernatant
constitutes the SOL fraction, and the cell pellets represent the CSK fraction that includes the
tubulin polymers. Cytoskeletal pellets were washed and resuspended in 0.25 mL PEM (0.1 M
PIPES, pH 6.9, 0.5 mM MgCl 2 , 1 mM EGTA) buffer, kept on ice for 15 min to depolymerize the
MTs, sonicated on ice for 1 min, and clarified by centrifugation. The protein concentration of the
samples was determined using the Bio-Rad protein assay, using bovine serum albumin (BSA) as
a standard.
2.3 Preparation of Whole-cell Extracts. PC12 cells were grown in 100-mm or 150-mm plates to
80% confluence over 1–2 days. Cells were then treated with or without 4-NP as indicated. The
medium was then removed and the cells were washed first with PBS and then with 0.5–1 mL
lysis buffer (10 mM Tris-HCl, pH 7.9, 1.5 mM MgCl 2 , 0.3 M sucrose, 1 mM DTT and protease
inhibitor cocktail). Cells were scraped with a cell scraper, sonicated for 1 min, followed by
centrifugation at 10,000 × g for 10 min. Supernatants represent whole-cell protein extracts.
Protein concentrations were typically between 1–2 mg/mL.
2.4 Immunoprecipitation. For immunoprecipitation, 100–200 µL aliquots of cellular fractions
(~0.25–1 mg/mL) were incubated with or without anti-Gβ-protein specific antibody (rabbit
polyclonal anti-Gβ, Santa Cruz Biotechnology, Santa Cruz, CA) for 1 h at 4 °C, followed by the
addition of 100 µL 50% protein A-sepharose (Amersham Biochemical, Piscataway, NJ), preequilibrated in 10 mM Tris-HCl, pH 8.0 at 4 °C, overnight. Samples were then centrifuged at
10,000 × g for 6 min, and the supernatants (SUP) were saved. The pellets (immunocomplex)
were washed with PBS, eluted with 3% SDS Laemmli sample buffer containing 0.15 M
dithiothreitol (DTT), and boiled in a water bath for 5 min. Samples were then clarified by
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centrifugation and they represented immunoprecipitants (IP). Both IP and SUP fractions were
subjected to immunoblotting using anti-α-tubulin (DMIA, mouse monoclonal from SigmaAldrich).
2.5 Electrophoresis and Immunoblotting. Samples for immunoblotting were subjected to SDSpolyacrylamide gel (10%) electrophoresis, followed by electrotransfer onto nitrocellulose
membranes. The membranes then were incubated in 5% non-fat dry milk in TBS (10 mM TrisHCl and 150 mM NaCl, pH 7.4) for 1 hour at room temperature, followed by an overnight
incubation with anti-Gβ or anti-tubulin antibodies (1:250) in TBS containing 0.01% BSA. The
membranes were washed with 0.05% Tween-20 in TBS (TBST) and incubated with the
appropriate HRP-conjugated secondary antibodies (goat anti-mouse and goat anti-rabbit from
Promega (Madison, WI), (1:1000) in TBST containing 0.01% BSA for 1 h at room temperature.
For sensitive detection, the chemiluminescence (ECL) technique (SuperSignal West Pico
Chemiluminescent Substrate) was used according to the manufacturer’s (Pierce Biotechnology,
Rockford, IL) instructions. Quantitative analysis was done using LabWorks image acquisition
and analysis software (UVP Laboratory Products, Upland, CA).
2.6 Confocal Microscopy. For confocal microscopic analysis, PC12 cells were allowed to attach
to immunocytochemistry slides (Lab-TEK II mounted on glass slides, VWR) and were grown
overnight in DMEM with bovine calf serum and penicillin-streptomycin as described above.
Cells were then treated with or without NGF, and subsequently fixed by the addition of ice-cold
100% methanol (previously cooled to -20 °C) and incubated at -20 °C for 6 min. The cells were
then rinsed three times in 1% NGS in PBS and blocked for 1 h at room temperature in 5%
normal goat serum (NGS) (Sigma-Aldrich) in PBS, followed by an overnight incubation at 4 °C
with primary antibodies (mouse monoclonal anti-tubulin, and/or rabbit polyclonal anti-Gβ) in
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PBS containing 1% NGS. The slides were rinsed as before and incubated for 2 h with the
appropriate secondary antibodies (rhodamine-conjugated goat anti-mouse, fluoresceinconjugated goat anti-rabbit, and Alexa Fluor 350 donkey anti-goat, Molecular Probes-Invitrogen,
Carlsbad, CA) in the dark to diminish photo-bleaching effects. The slides were then rinsed,
mounted with DAKO mounting media (DAKO Corp., Carpenteria, CA), and covered with
coverslip. High resolution, digital, fluorescent images were captured employing inverted,
confocal laser scanning microscopy (model LSM 700; Zeiss, New York), utilizing a PlanApochromat 63x/1.40 immersion-oil DIC objective and assisted with ZEN 2009 software (Zeiss,
New York, NY). Alexa Fluor 350 (blue), FITC (green), and rhodamine (red) were excited with
laser emissions at 405-, 488-, and 555-nm wavelengths, respectively.
2.7 Overexpression of Gβγ. PC12 cells were transiently co-transfected with YFP-tagged
pcDNA3.1 plasmids encoding for Gβ1 and Gγ2 subunits. The expression plasmids were
provided by Dr. N. Gautam (Washington University, St. Louis). A plasmid encoding only YFP
(pcDNA3-YFP, Addgene, Cambridge, MA) was used as control. The plasmids were transfected
separately (Gβ1, and Gγ2), or co-transfected to generate the Gβ1γ2 combinations. Cells were
transfected with the plasmids using Lipofectamine LTX PLUS reagent (Invitrogen) according to
the manufacturer’s instructions. Briefly, PC12 cells were seeded on glass coverslips using 12well plates at a density of 50,000 cells/well, and they were incubated overnight under normal
growth conditions. The following day, the cells were transfected with a mixture of
Lipofectamine LTX PLUS containing 2 µg of each plasmid dissolved in antibiotic-free media
and incubated under normal conditions overnight. Cells were monitored for protein expression
(YFP fluorescence) and for morphological changes using differential interference contrast (DIC)
images at different time points (24, 48, and 72 h), using a Zeiss Axiovert 200 fluorescence
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microscope equipped with a GFP filter. For confocal microscopic analysis, the cells were fixed
and processed as described above (confocal microscopy).
2.8 Differential nuclear staining (DNS) assay for cytotoxicity. To determine the levels of
cytotoxicity caused by the 4-NP, a previously described DNS assay adapted for high-throughput
screening was used (Lerma et. al., 2011). This assay uses two fluorescent nucleic acid
intercalators, Hoechst 33342 (Hoechst) and propidium iodide (PI). Briefly, PC12 cells were
seeded in a 96-well plate format and incubated with NGF and 4-NP. One h before image
capturing, cells were added with a staining mixture of Hoechst and PI at a final concentration of
1 µg/mL for each dye. Subsequently, cells were imaged in live-cell mode using a BD Pathway
855 Bioimager system (BD Biosciences, Rockville, MD). Montages (2x2) from four adjacent
image fields were captured per well in order to acquire an adequate number of cells for statistical
analysis, utilizing a 10x objective. To determine the percentage of dead cells from each
individual well, both image acquisition and data analysis were performed using the BD
AttoVision v1.6.2 software (BD Biosciences), and each experimental condition was assessed in
triplicate.
2.9 Neurite outgrowth assessment. For neurite outgrowth measurement, cells were fixed and
processed for confocal microscopy using a mouse monoclonal anti-tubulin antibody and a rabbit
polyclonal Gβ antibody, followed by labeling with rhodamine- and FITC-conjugated secondary
antibodies. Due to the fast photo-bleaching of the FITC fluorophore, the cells were only imaged
using rhodamine staining for the purpose of neurite outgrowth assessment. Cells were viewed
using the 40x objective with a Zeiss LSM 700 confocal microscope. The coverslips were
scanned from left to right, and 8–10 fields were randomly selected. For each field, neurites were
traced and measured using the 2009 ZEN software (Zeiss), and at least 100 cells from three
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independent experiments were scored for each condition. A cell was considered as neuritebearing if it contained at least one neuronal process that was longer than the cell body.
2.10 Statistical analysis. All statistical analysis was performed using Sigma Plot 11 software. In
the case of Western-blot quantitative analysis, the differences between controls and treatments
were assessed by means of the student’s paired t-test. For comparisons between two groups, the
student’s paired t-test was employed. In all cases, a value of p < 0.05 was considered to be
statistically significant.
2.11 Sample Preparation for Proteomic analysis. PC12 cells were grown on four 100-mm plates
to 80% confluence over 2 days. Subsequently, plates were then treated with (3 and 4) or without
(plates 1 and 2) NGF for two consecutive days, followed by treatment with (plates 2 and 4) 10
μM 4-NP and NGF for an additional day, while the remaining plates (plates 1 and 3) were treated
only with NGF and served as controls. The Cytoskeletal (CSK) and soluble (SOL) fractions were
then prepared by extracting soluble proteins in an MT -stabilizing buffer (MS). The stabilizing
buffer contained 0.1 M PIPES, pH 6.9, 2 M glycerol, 5 mM MgCl 2 , 2 mM EGTA, 0.5% Triton
X-100, protease inhibitor cocktail (Sigma-Aldrich), 0.1 mM GTP, and 1 mM DTT. Briefly, cells
were rinsed and incubated with MS buffer (0.5–1 ml) for ~10 min at room temperature until cells
were beginning to lyse. Subsequently, cells were removed mechanically (using a cell scraper)
and centrifuged at 10,000 × g for 10 min. The supernatant constitutes the SOL fraction, and the
cell pellets represent the CSK fraction.

2.11.1 LC–MS/MS analysis: Protein pellets were re-suspended in 100 uL 0.4 M NH4HCO3
containing 8M urea and reduced with 5 mM DTT for 30 min at 55°C. Reduced thiol groups were
alkylated with 10 mM iodoacetamide for 30 min at room temperature, and diluted 8 fold to a
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final concentration of 1M urea, 50mM NH 4 HCO3. The samples were digested overnight at 37°C
with sequencing grade trypsin (Sigma-Aldrich). After quenching the reaction with TFA to a final
concentration of 0.05% TFA, the samples were desalted with 100mg C18 cartridges (Supelco)
and dried in a vacuum centrifuge.LC–MS/MS analyses were performed on an Ultimate 3000
RSLCnano system online coupled to a Q-exactive (Thermo Scientific). Peptides were introduced
to the analytical column (Acclaim® PepMap RSLC, 75 μm × 15 cm, nanoViper, C18, 2 μm,
100 Å) and separated using a 90 min gradient from 5 to 40% solvent B at a flow rate of
300 nl/min (solvent A: 0.1% formic acid 5 % acetonitrile, solvent B: 0.1% FA 80% acetonitrile).
The mass spectrometer was operated in a data-dependent mode. Full scan MS spectra were
acquired at a mass resolution of 70,000 (mass range 400–1600 m/z and a target value of 1E6) in
the Orbitrap analyzer. Tandem mass spectra of the 10 most abundant peaks of a full scan MS
spectrum were acquired following

peptide fragmentation using higher-energy collisional

dissociation (HCD) at a mass resolution 17,500 (target value of 2E5, NCE 28%, isolation width
4 m/z). The dynamic exclusion time was 15 s.

2.11.2 Protein identification: Protein identifications were performed with Proteome Discoverer
software. Briefly, raw-files were searched against UniProtKB/Swiss-Prot database (taxonomy rat
and common contaminant proteins) using Sequest. For database searches, mass tolerances were
set to 10 ppm and 0.02 Da for precursor and fragment ions, respectively. For analyses two
trypsin missed cleavages were allowed, modifications of cysteine (carbamidomethyl, static),
methionine (oxidation, variable) and asparagine, glutamine (deamidation, variable) were
considered. Confidence of peptide identifications was determined using percolator function, in
Proteome Discoverer. Peptide identifications with false discovery rates > 1% (q-value > 0.01)
were discarded.
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CHAPTER 3: RESULTS

3.1 Specific Aim-1: Does 4-NP inhibit neurite outgrowth and differentiation and induce
neurodegeneration by interfering with the MT-Gβγ mediated pathway?
3.1.1 Objective and Overview
Dynamic rearrangements of MTs are critical for growth-cone motility and neurite
outgrowth. Previous studies have shown that the βγ subunit of signal-transducing G proteins
promotes MT assembly (Roychowdhury and Rasenick, 1997; Roychowdhury et al., 1999;
Roychowdhury et al., 2006; Montoya et al., 2007; Roychowdhury and Rasenick, 2008). More
recently, it was found that NGF-induced neuronal differentiation of PC12 cells promotes the
interactions of Gβγ with MTs and stimulated MT assembly. Overexpression of Gβγ in PC12
cells induced neurite formation in the absence of NGF. Furthermore, the Gβγ−sequestering
peptide GRK2i inhibited neurite formation, disrupted MTs, and induced axonal damage (SierraFonseca, Martinez-Jurado et. al., Manuscript under preparation), suggesting that the Gβγ-MT
mediated pathway played a critical role in inducing neurite outgrowth and neurodegeneration.
Because 4-NP has been shown to block NGF-induced neurite outgrowth, in Specific Aim-1 I
examined the role of 4-NP in dynamic interactions between Gβγ and MTs during neuronal
outgrowth and differentiation, using PC12 cells. NGF-induced neuronal differentiation, as well
as overexpression of Gβγ, was used to address whether NP interferes with Gβγ-MT mediated
pathways.
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3.1.2 4-NP inhibits NGF-induced neuronal differentiation of PC12 cells and induces
cellular aggregation and degeneration by altering the Gβγ-MT association
To determine the role of 4-NP on neurite outgrowth and development, we tested the effects of 4NP on NGF-induced neuronal differentiation of PC12 cells using confocal microscopy. PC12
cells were allowed to attach in immunocytochemistry slides and grow overnight as indicated in
the methods. Cells were then treated with or without NGF for three consecutive days to induce
neuronal differentiation. Subsequently, cells were treated with or without 4-NP for 1 h and
subjected to confocal miscopy as indicated in the methods. Tubulin was detected with a
monoclonal, anti-tubulin antibody (red), Gβγ was identified with rabbit polyclonal anti-Gβ
antibody (green), and DAPI staining (blue) represented nuclear labeling (Figure 6.1). Areas of
co-localization between MTs and Gβγ appear yellow. As indicated in the figure, in the controlPC12 cells (in the absence of NGF) Gβγ were co-localized with MTs mainly in the perinuclear
region and those cells displayed typical morphology (Figure 6.1, upper panel). After NGF
treatment, Gβγ co-localized with MTs in both the cell body and the neuronal processes (Figure
6.1, lower panel). In the presence of 4-NP at 1 μM, the lowest concentration used, there are some
noticeable morphological changes. Cells started to shrink and neurites shortened in comparison
to the control cells. Consequently, at a concentration of 5 μM, aggregation of cells occurred and
neurites were absent in most cells (Figure 7.1). At a higher concentration, 10 µM, 4-NP had
more profound effects on blocking neurite formation and cellular degeneration, as expected.
Many cells lost their shapes, processes were curly, and absent nucleus and cell aggregation was
observed (Figure 7.1).
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[Figure 6.1 NGF-Induced Neuronal differentiation of PC12 cells: Co-localization of Gβγ with
MT in the neuronal processes. PC12 cells were treated with 100 ng/ml NGF for three
consecutive days to induce neuronal differentiation. Samples were then fixed and stained with
mouse monoclonal anti-tubulin and rabbit polyclonal anti-Gβ antibodies. Co-localization patterns
of Gβγ (green) and tubulin (red) are shown by double immunofluorescence labeling. Blue
represents nuclear labeling. In NGF treated cells, neurite outgrowth was observed. Colocalization between MTs and Gβγ (yellow) was observed mainly in the neuronal processes].
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[Figure 7.1 Effect of 4-NP on NGF-Induced Neuronal differentiation of PC12 cells. PC12 cells
were treated with 100 ng/ml NGF for three days to induce neuronal differentiation. Cells were
then treated with 4-NP at 1μM, 5μM and 10μM. Samples were then fixed and stained with
mouse monoclonal anti-tubulin and rabbit polyclonal anti-Gβ antibodies. Co-localization patterns
of Gβγ (green) and tubulin (red) are shown by double immunofluorescence labeling. Blue
represents nuclear labeling. In NGF treated cells, neurite outgrowth was observed. Colocalization between MTs and Gβγ (yellow) was observed mainly in the neuronal processes].
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3.1.3 Neurite-outgrowth assessment after 4-NP treatment
Measurement of the number and length of neurites provided a quantitative assessment of
neuronal differentiation. Therefore, the effect of 4-NP on neuronal differentiation was assessed
by measuring average neurite lengths as well as the percentage of cells bearing neurites (Figure
8.1). To accomplish this, neurites were traced and measured using the 2009 ZEN software from
Carl Zeiss, Inc. (Thornwood, NY). At least 100 cells from three independent experiments were
scored for each condition in this assessment. A cell was considered neurite-bearing if it
contained at least one neuronal process that was longer than the cell body (X µm in diameter).
As indicated in Figure 8.1A, the percentage of cells bearing neurites was reduced significantly—
from 55% in the control cells to 20% after 30 min of incubation with 1 μM 4-NP and further
reduced to 5% in the presence of 5 μM 4-NP. Interestingly, the average neurite length of
surviving neurites did not decease in the presence of 4-NP (Figure 8.1B). In fact, in the presence
of 5 μM 4-NP, the average neurite length was found to be increased. This suggests that NGFinduced neurites are not equally susceptible to 4-NP, and a population of differentiated cells with
longer neurites are resistant to 4-NP.
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**

[Figure 8.1 Assesment of neurite outgrowth after 4-NP treatment. PC12 cells were treated with
100 ng/ml NGF for three days to induce neuronal differentiation. Cells were then treated with
1μM, and 5μM 4-NP followed by fixing and processing for confocal microscopy as described
previously. Using the Zeiss ZEN software, neurites were traced and measured and expressed as
percent of cells bearing neurites (A) and average neurite length (B). Differences between
experimental conditions were assessed by one-way ANOVA. **p < 0.001]
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3.1.4 Overexpression of Gβγ in PC12 cells induces neurite outgrowth in the absence of
NGF; 4-NP inhibits this process and promotes neurodegeneration
Recently, our laboratory has shown that the overexpression of Gβγ induces neurite
outgrowth from PC12 cells in the absence of NGF (Sierra-Fonseca, Martinez-Jurado et al.,
Manuscript under preparation). Therefore, to confirm the role of 4-NP in blocking neuronal
differentiation and inducing neurodegeneration, we overexpressed Gβγ in PC12 cells. To
accomplish this, PC12 cells were co-transfected with Gβ1 and Gγ2. YFP-tagged Gβ1 and Gγ2
constructs (YFP-Gβ1 and YFP-Gγ2) were used for transfection. A plasmid encoding just YFP
was used as control. Cells were monitored for protein expression and possible neurite formation
at different time points (24 h and 48 h). Within 24 h of transfection, β1γ2-transfected PC12 cells
were found to overexpress the proteins as indicated by green fluorescence. At 48 h of
transfection, YFP-β1γ2-transfected cells induced neurite formation in the absence of NGF
(Figure 9.1, control). Cells were then treated with 4-NP (.2 µM, 1 µM or 10 µM) for 1 hour, and
fixed and processed for confocal microscopy using anti-tubulin antibody (red). At a lower
concentration, 4-NP (0.2 μM) displayed an absence of neurites and disruption of cells barely
started to show. In the presence of 1 μM 4-NP, cellular aggregation as well as cell disruption
occurred. As expected, 4-NP at a concentration of 10μM was most effective. Cellular
aggregation, cell disruption, and nuclear damage were clearly visible at 10 µM 4-NP (Figure
9.1).
From confocal microscopic examination, I conclude that 4-NP inhibits Gβγ-induced
neuronal differentiation of PC12 cells and induces neurodegeneration.
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[Figure 9.1 Overexpression of Gβγ induces neurite outgrowth: 4-NP inhibits this process. PC12
cells were co-transfected with YFP-tagged Gβ1 and Gγ2 (β1γ2), using Lipofectamine LTX
PLUS reagent. A construct encoding only YFP tag was used as control. Cells were treated at
different concentrations with NP and morphological changes were observed using a fluorescence
microscope.]
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3.1.5 4-NP does not affect MT assembly but increases tubulin expression significantly
To understand the role of 4-NP and its link to MT assembly, we evaluated the effect of 4NP in PC12 cells. To conduct the experiment, PC12 cells were treated with or without 10μM 4NP. Cytoskeletal (CSK, enriched in MTs) and soluble protein fractions (SOL, enriched in
dimeric tubulin) were separated as indicated in the methods. Tubulin immunoreactivity was
measured in both fractions, and MT assembly was assessed by calculating the % of Tubulin in
CSK fraction. We found that MT-assembly was not significantly decreased in PC12 cells after
treatment at 10μM 4-NP (Figure 10.1). Treatment with 4-NP decreased MT assembly from
43.52% in control cells to 41.52% in treated cells. Previous studies indicated that Gβγ associates
with microtubules and this association is important for microtubule assembly (Roychowdhury
and Rasenick., 1997; Montoya et. al., 2007). Therefore we determined if Gβγ association with
MTs were alter after 4-NP treatment. We found that 47.5% Gβγ was associated with MTs and 4NP did not have any significant effect on this association.
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[Figure 10.1 Effect of 4-NP on MT assembly. PC12 cells were treated with 4-NP at a
concentration of 10μM for 1 hour. After incubation, subcellular fractionation was performed and
CSK and SOL fractions were subjected to Western blot using anti-tubulin antibody as indicated
in the methods. Protein bands were detected using the ECL-plus reagent, quantitated. MT
assembly was determined by assessing tubulin immunoreactivity in both fractions, and it is
expressed as percent tubulin in CSK fraction. The graphic shows percent tubulin in CSK
fractions. A representative experiment is shown. Values shown represent mean ± standard error
of two independent experiments done in duplicates. No significant change was found]

To determine if 4-NP affected tubulin or Gβγ expression in the PC12 cells, we performed
a whole-cell lysate extraction after treatment with 4-NP. The samples were processed for western
blotting using anti-tubulin and anti-Gβ antibodies as described in the methods. As indicated in
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the figure (Figure 11.1A) tubulin expression was significantly increased in the presence of 4-NP,
while Gβγ expression remained unaltered after 4-NP treatment (Figure 11.1B).

[Figure 11.1 Effect of 4-NP on the expression of Gβγ and Tubulin. PC12 cells were treated with
4-NP at a concentration of 10 µM for 1 hour. After incubation, extraction was performed and
whole cell lysate samples were prepared and subjected to Western blot using (A) anti-tubulin
antibody or (B) anti-Gβ antibody as indicated in the method. Protein bands were detected using
the ECL-plus reagent, quantitated, and expressed. Values shown represent mean ± standard error
of one experiment done in duplicates]

It is known that tubulin undergoes several post-translational modifications, including
tyrosination-detyrosination (addition or removal of tyrosine at the c-terminal end of α-tubulin),
and these modifications are important for MT stability. MTs with detyrosinated tubulin (also
known as Glu-tubulin) are more stable than MTs comprised of more tyr-tubulin. Because tubulin
expression was increased in the presence of 4-NP, we tested whether 4-NP affects the expression
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of a specific form of tubulin. As indicated in Figure 11.1, whole-cell lysates were prepared from
PC12 cells, treated both in the presence and absence of 4-NP, and subjected to western blotting
using anti-tyrosinated tubulin and anti-glutamylated tubulin antibodies. Both tubulin subtypes
were affected in the presence of 4-NP (Figure 12.1); however, the effect was more pronounced
with glutamylated (Glu-tub) tubulin.

[Figure 12.1 Effect of 4-NP on the expression of Tyrosine and Glutamine Tubulin. PC12 cells
were treated with 4-NP at a concentration of 10 µM for 1 hour. After incubation, extraction was
performed and whole cell lysate samples were prepared and subjected to Western blot using (A)
anti-tyr-tubulin antibody or (B) anti-glu-tubulin antibody as indicated in the method. Protein
bands were detected using the ECL-plus reagent, quantitated, and expressed. Values shown
represent mean ± standard error of one experiment done in duplicates.]
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3.1.6 4-NP does not induce neuronal cell death
To determine if 4-NP induced neuronal cell death at the concentrations used, DNScytotoxicity assay was performed as described in the method. This assay uses two fluorescent
dyes —Hoechst, which is membrane-permeable and stains the nuclei of both living and dead
cells, and propidium iodide (PI), which is only able to enter cells with compromised plasma
membranes, thus selectively staining the nuclei of dead cells. PC12 cells were grown on 96 well
plates and incubated with NGF and 4-NP at a concentration of 10 μM, followed by 1 h
incubation with a mixture of Hoechst/PI at a final concentration of 1 µg/ml. Subsequently, cells
were imaged in live mode using a BD Pathway 855 Bioimager system (BD Biosciences) as
described in the methods section. The percentage of dead cells in the presence of 4-NP was
determined using the BD AttoVision v1.6.2 software (BD Biosciences), and the result was
plotted (Figure 12.1B). As indicated in the figure, 4-NP did not cause cytotoxicity on NGFdifferentiated PC12 cells and no significant cell death was detected. Hydrogen peroxide (100
µM) was used as a positive control (Figure 12.1A).
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[Figure 13.1 4-NP does not induce neuronal cell death. PC12 cells were grown on 96-well plates
and treated with NGF and inhibitors as indicated in Methods. Subsequently, cells were incubated
with a Hoechst/propidium iodide (PI) mixture for DNS cytotoxicity assay. The images were
captured in live-cell-image mode using confocal automated microscope BD Pathway Bioimager
system and a 10x objective, assisted with AttoVision software. (A) Representative images
corresponding to the same section of 2 x 2 image montages from several conditions (a–l) are
shown. H 2 O 2 (100 µM) was used as a positive control. Cell nuclei stained with Hoechst provide
the total number of cells; cell nuclei stained with PI indicate the number of dead cells; merged
Hoechst and PI images, where the magenta color is a consequence of the co-localization of red
and blue colors, indicating the number of dead cells in the image. (B-C) Cell death was plotted
as the percent of PI-positive cells, denoting the total number of dead cells for each condition.]
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3.2 Specific Aim-2: Does 4-NP alter cytoskeleton and associated proteins to induce
neurodegeneration?
3.2.1 Objective and Overview:
The molecular pathways leading to neurodegeneration are not well understood. As
indicated in Figure 2, amyloid plaques and neurofibrillary tangles (NFTs) constitute the two
major neuropathologic alterations present in Alzheimer’s disease (AD) brains. The majority of
past research and drug discovery efforts in the area of neurodegenerative diseases have focused
on these pathological markers. Although previous research has advanced our understanding of
the pathology of neurodegenerative disorders significantly, the cause of these disorders remains
largely unknown. Most importantly, no effective drugs are currently available to treat these
neurodegenerative disorders suggesting that there is a critical knowledge gap in our
understanding of how the diseases are triggered and progress. Results from Specific Aim-1
indicate that 4-NP inhibits neurite outgrowth from PC12 cells, alters MT and Gβγ organization,
and induces cellular aggregation and neurodegeneration. To better understand the role of 4-NP in
the disruption of the cytoskeleton and neurodegeneration, in Specific Aim-2, I conducted
proteomic analysis of cytoskeletal fractions (CSK) to determine how 4-NP altered the
cytoskeleton and associated proteins to induce neurodegeneration. We also attempted
biochemical and microscopic analysis to determine whether 4-NP induces aggregation of tau
protein while inhibiting neuronal outgrowth and differentiation.
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3.2.2 The expression of tau protein increased significantly in the presence of 4-NP
Tau is a microtubule-associated protein found only in axons and it is known to regulate MT
assembly and neurite outgrowth. Abnormal phosphorylation of tau is associated with several
human neurodegenerative disorders known as taupathies (Alonso et al., 2008; Amniai et al.,
2008; Gustav-Rothenberg et al., 2010). In an effort to understand whether 4-NP alters the
localization of tau proteins and induces tau aggregation in NGF-differentiated PC12 cells,
confocal microscopic analysis was attempted using antibodies specific to tau protein (from
Sigma Chemicals). However, two different tau antibodies (monoclonal and polyclonal
antibodies) failed to detect tau labeling in NGF-differentiated PC12 cells. Unlike confocal
microscopic analysis, tau expression was detected in cell lysates in NGF-differentiated PC12
cells using immunoblot analysis (Figure 14.1). The expression of tau protein is known to
increase during neuronal differentiation. It was found that tau expression significantly increased
in the presence of 4-NP similar to that observed with tubulin.
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[Figure 141. Effect of 4-NP on the expression of Tau. PC12 cells were treated with 4-NP at a
concentration of 10 µM for 1 hour. After incubation, extraction was performed and whole cell
lysate samples were prepared and subjected to Western blot using tau antibody as indicated in
the method. Protein bands were detected using the ECL-plus reagent, quantitated, and expressed.
Values shown represent mean ± standard error of one experiment done in duplicates].
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3.2.3 Proteomic analysis of cytoskeletal fraction (CSK)
The cytoskeleton plays a key role in maintaining the highly asymmetrical shape and
structural polarity of neurons that are essential for neuronal functions, and is composed of three
major protein filaments: actin filaments, microtubules, and intermediate filaments. In addition to
several microtubules and actin-associated proteins, motor proteins are also integral components
of neuronal cytoskeleton. However, the cytoskeleton is not a static structure. It is highly dynamic
in nature with an inherent ability to assemble and disassemble in response to diverse signals. The
identity of many of these signaling molecules and how they network spatially within the cell to
regulate cytoskeleton remodeling is not well understood and is critical for our understanding of
the mechanisms of neurodegeneration. To address this, we carried out proteomic analysis of
cytoskeletal fractions both in the presence and the absence of 4-NP. Both control PC12 cells and
NGF-differentiated PC12 cells were used for this study.

Proteomic Analysis by mass spectrometry provides a valuable tool to analyze the large
numbers of proteins in complex samples and was used for protein analysis of cytoskeletal
fraction. Primarily, protein samples were digested with trypsin (residue-specific protease)
followed by electrospray ionization directly into the source of a mass spectrometer. Applying a
strong electric field performs nebulization of the fluid (containing the sample), and charge
peptides by proton attachment. The samples were then delivered to the first mass spectrometer
(MS-1), where the peptides are identified based on their mass to charge ratio (m/z). The mass
spectrometer acquires spectra of the eluting peptides and fragments the most abundant peptide
ions in turn. Fragmentation was carried out by collision with an inert gas and occurs mainly at
the amide bonds of the peptide, resulting in a set of peptides differing by the mass of one amino
acid. The second mass spectrometer (MS-2) analyzes the m/z ratios of the resulting peptide
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fragments (Liand and Assmann, 2000). The tandem mass spectra (MS/MS) are then searched
against protein databases resulting in the identification of a large number of peptides from which
a protein list is compiled (Pandey and Mann, 2000).
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3.2.4 Proteomic analysis of cytoskeletal fraction reveals the association of G protein
subunits with the cytoskeleton in PC12 cells; NGF appears to modulate this association
Cytoskeletal fraction from PC12 cells was subjected to LC-MS/MS analysis in the Orbitrap
analyzer as described in the methods. Protein identifications were performed with Proteome
Discoverer software. As expected, many cytoskeletal proteins were identified in cytoskeletal
fractions of control PC12 and NGF-differentiated PC12 cells. As predicted from previous studies
from our laboratory and the current investigation, G protein β-subunits were also identified
consistently in CSK both in control and NGF-differentiated PC12 cells. Lists of protein
identification with a minimum of two peptides were used. Several proteins of interest—i.e,
cytoskeletal proteins including tubulin and heterotrimeric G protein subunits—are listed in Table
1.1 (control PC12 cells) and Table 2.1 (NGF-differentiated PC12 cells). As indicated in the
tables, several tubulin isotypes were found in the cytoskeleton fraction with a high score,
reflecting the abundance of these isotypes in CSK. Regarding G protein subunits, Gβ2 and Gβ2like proteins were consistently associated with CSK fractions of both control and NGF-treated
PC12 cells (Table 1.1 and 2.1). NGF-induced differentiation of PC12 cells differentially
regulated several proteins. Tubulin and G protein subunits, up- or down-regulated by NGF
treatment are in Table 3.1. The fold change is computed as the value that maximizes the
likelihood function representing differential expression in spectral counts. FDR (false discovery
rate) is calculated from the significance statistics. Notable changes were found with G(i) alpha 2,
which was up-regulated dramatically (long-fold change 1.7. p value .0035 ) in the presence of
NGF. Conversely, the Gbeta 2-like protein was down-regulated in the presence of NGF. In
addition, tubulin beta 5, MAP-1A, was also up-regulated in the presence of 4-NP. It is
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anticipated that these data will allow us to better understand the mechanism of NGF-induced
neuronal differentiation.
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3.2.5 4-NP alters the expression of tubulin isotypes and several cytoskeletal proteins in
NGF-differentiated PC12 cells
Proteomic analysis of CSK fraction indicates that 4-NP up-regulates expression of several
tubulin isotypes in NGF-differentiated PC12 cells (Table 4.1). This data is interesting and
support our western blot results indicating the increased expression of tubulin in the presence of
4-NP in NGF-differentiated cells (Figures 11.1 and 12.1). As indicated in Table 4.1, the tubulin
alpha chain-like protein was up-regulated profoundly (about 70 fold) after 4-NP treatment, which
suggests a possible role of this tubulin subtype in 4-NP-induced neuronal degeneration. As
indicated in Table 4.1, expressions of Gbeta subunits were not affected by 4-NP treatment.
However, in addition to tubulin, several cytoskeletal proteins were up- or down-regulated in the
presence of 4-NP (Table 4.1). Interestingly, cortactin, an actin-binding protein was downregulated after 4-NP treatment although it up-regulated significantly in NGF-differentiated cells,
suggesting that 4-NP may target this protein to induce neuronal damage. We also carried out
proteomic analysis of CSK fraction after treatment with 4-NP in control PC12 cells (without
NGF treatment). The data shown in Table 5.1 indicates that tubulin isotypes were not affected in
PC12 cells, and the effect of 4-NP was specific in NGF-differentiated PC12 cells. Interestingly,
G beta2-like protein and G(i) alpha2 were down-regulated in the presence of 4-NP. We also
found tropomyosin alpha-3 chain, and inositol 1,4,5-tryphosphate receptor type-3 was
consistently associated with CSK fraction and was up-regulated in 4-NP treated cells.
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TABLE 1.1 : Tubulin and heterotrimeric G protein subunits enriched in Cytoskeletal fraction of
PC12 cell

Accession
No.
P68370
Q6P9V9
QbAyz1
P85108
Q5XIF6
Q4qRB$
P69897
G5ATH6
P54313
G3V6P8

P63245
GJBMR4
D4A8C9

P34926
P15205
G5BF21

PROTEIN ID

Scores

Tubulin alpha 1A
Tubulin alpha 1B
Tubulin alpha 1C
Tubulin alpha 2A
Tubulin alpha 4A
Tubulin beta-3
Tubulin beta-5
Guanine Nucleotide binding protein
G(I)/G(S)/G(T) subunit beta-1
Guanine Nucleotide binding protein
G(I)/G(S)/G(T) subunit beta-2
Guanine Nucleotide binding protein subunit
gamma
Guanine Nucleotide binding protein Gi
alpha2
Guanine Nucleotide binding beta-2 like
Guanine Nucleotide binding protein protein
G(O) subunit alpha
Guanine Nucleotide binding protein like 3
Lamin A
Cortactin
Tropomyosin alpha-3 chain
Inositol 1,4,5- tryphosphate receptor type-3
Alpha-actinin-4
Actin cytosplasmic-1
Peripherin
Microtubule-associated protein 1A
Microtubule-associated protein 1B
Microtubule-associated protein 1A/1B light
chain 3B

n.d Not Detected
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Peptide

416.58
551.47
359.59
656.5
361.79
369.14
751.02

Unique
Peptides
1
4
2
1
4
2
4

M.Wt
(KDa)

22
20
22
20
19
20
25

49.9
49.6
50.4

35.49

8

8

37.3

222.49
n.d

17

17

35.1

47.12

8

8

57

5.01
8.58
5.99

2
2
2

2
2
2

299.3
269.3
12.9

n.d
n.d

TABLE 2.1 : Identity of proteins in the Cytoskeletal fraction of NGF-differentiated PC12 cells
Accession
No.
Q6P9V9

Q5XIF6
Q4QRB4
P69897

P54313

G3V6P8
G5BMR4

P63245
Q81159
D4A8C9

P34926
P15205
E9PTL3
G5BF21

PROTEIN ID
Tubulin alpha 1A
Tubulin alpha 1B
Tubulin alpha 1C
Tubulin alpha 2A
Tubulin alpha 4A
Tubulin beta-3
Tubulin beta-5
Guanine Nucleotide binding
protein G(I)/G(S)/G(T) subunit
beta-1
Guanine Nucleotide binding
protein G(I)/G(S)/G(T) subunit
beta-2
Guanine Nucleotide binding
protein subunit gamma
Guanine Nucleotide binding
protein protein G(O) subunit
alpha (Fragmented)
Guanine Nucleotide binding
beta-2 like
Guanine Nucleotide binding
protein like 3
Lamin A
Cortactin
Tropomyosin alpha-3 chain
Inositol 1,4,5- tryphosphate
receptor type-3
Alpha-actinin-4
Actin cytosplasmic-1
Peripherin
Microtubule-associated protein
1A
Microtubule-associated protein
1B
MAP
Microtubule-associated protein
1A/1B light chain 3B (Fragment)

Scores

Unique
Peptides

Peptide

414.37
642.41
391.93
303.8
786.64

9
2
6
2
4

19
21
16
20
25

49.9
49.6
50.4

34.28

9

9

37.3

7.80

2

2

8

22.88

3

6

144.72

18

18

35.1

71.78

13

13

60.6

6.53
3.21

2
2

2
2

52.9
12.9
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M.Wt
(KDa)

TABLE 3.1: Effect of NGF on the upregulation and downregulation of cytoskeletal and GTPbinding proteins in PC12 cells.

PROTEIN

Tubulin alpha 1B
Tubulin alpha 1C
Tubulin alpha 4A
Tubulin beta-3
Tubulin beta-5

UP-OR DOWNREGULATED/LOG FOLD
CHANGE
n.c
n.c
n.c
n.c
↑ 0.19

FDR

0.037831

n.c

Guanine Nucleotide binding beta1
Guanine Nucleotide binding beta2
Guanine Nucleotide binding
gamma
Guanine Nucleotide binding
protein G(i) subunit-alpha2
Guanine Nucleotide binding beta2 like
Lamin A
Cortactin
Tropomyosin alpha-3 chain
Inositol 1,4,5- tryphosphate
receptor type-3
Alpha-actinin-4

n.c
n.c

Microtubule-associated protein
1A
Microtubule-associated protein
1B
Microtubule-associated protein
↑ upregulation
↓ downreagulation
n.c. No Change
n.s Not significant
FDR (False Discovery Rate), <.05 significant
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↑ 1.709

0.0035

↓-0.401

0.009

↑ 0.245
↑ 1.134
↑0.371
↑ 0.697

0.0
.01
0

↓ -0.29

0.000868

↑1.229

n.s

↑ .68

n.s

↑ 1.3

n.s

TABLE 4.1: Effect of 4-NP on the upregulation and downregulation of cytoskeletal and GTPbinding proteins in NGF-differentiated PC12 cells

PROTEIN

Tubulin alpha 1C
Tubulin alpha 1B
Tubulin alpha 4A
Tubulin alpha chain-like 3
Tubulin beta-3
Tubulin beta-5
Guanine Nucleotide binding protein
G(I)/G(S)/G(T) subunit beta-1
Guanine Nucleotide binding protein
G(I)/G(S)/G(T) subunit beta-2
Guanine Nucleotide binding protein
subunit gamma
Guanine Nucleotide binding protein Gi
alpha2
Guanine Nucleotide binding beta-2 like
Guanine Nucleotide binding protein like
3
Guanine Nucleotide binding protein
G(O) subunit alpha

UP-OR DOWNREGULATED/LOG
FOLD CHANGE (+4NP)
↑ 0.38
↑ 0.34
↑ 0.443
↑1.968
↑ 0.69
↑0.377
n.c

FDR

.000001
.000023
0.0
.000985
0.0
0.0

n.c
n.c
n.c
n.c
n.c
n.c
↓ -.66

Cortactin

n.c
n.c
n.c
n.c
n.c
n.c
n.c
n.c

Alpha actinin-4
Actin cytosplasmic-1
Peripherin
Microtubule-associated protein 1A
Microtubule-associated protein 1B
Microtubule-associated protein 6
Microtubule-associated protein 1
Microtubule-associated protein
↑ upregulation
↓ downreagulation
n.c. No Change
FDR (False Discovery Rate), <.05 significant

45

0.002308

TABLE 5.1 Effect of 4-NP on the upregulation and downregulation of cytoskeletal and GTPbinding proteins in PC12 cells (in absence of NGF).

PROTEIN
Tubulin alpha 1C
Tubulin alpha 1B
Tubulin alpha 4A
Tubulin beta-3
Tubulin beta-5
Guanine Nucleotide binding
protein G(I)/G(S)/G(T)
subunit beta-1
Guanine Nucleotide binding
protein G(I)/G(S)/G(T)
subunit beta-2
Guanine Nucleotide binding
protein subunit gamma
Guanine Nucleotide binding
beta-2 like 1
Lamin A
Cortactin
Tropomyosin alpha-3 chain

UP-OR DOWNREGULATED (-NGF)
n.c
n.c
n.c
n.c
n.c
n.c

Inositol 1,4,5- tryphosphate
receptor type-3
Alpha-actinin-4
Peripherin

FDR

n.c

↓-0.533

0.0038

n.c
n.c
↑ 0.85

0.003523

n.c
n.c
↑ .029

↑ upregulation
↓ downreagulation
n.c. No Change
FDR (False Discovery Rate), <.05 significant
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0.000293

CHAPTER 4: DISCUSSION

Because the U.S population is growing older, and aging is the most consistent risk factor of
developing a neurodegenerative disorder, neurodegenerative diseases are expected to surge in the
coming years. Since the pathogenesis of many of these diseases is unknown, the role of
environmental factors must be considered. Until recently, the major concerns of environmental
factors on human health were centered on potential roles in cancer. However, attention is now
focused on understanding the damaging role of environmental factors on developing and mature
nervous systems. Recent evidence suggests that environmental chemicals that act as endocrine
disruptors (EDC) may adversely affect brain development and induce neurodegeneration. The
results presented in this study demonstrate that 4-Nolylphenol (4-NP), an EDC, inhibits NGFinduced neuronal differentiation of PC12 cells by altering MT-Gβγ association. Dynamic
rearrangement of microtubules (MTs) is critical for growth-cone motility and neurite outgrowth.
Previously, Gβγ has been shown to play a key role in this process by stimulating MT assembly
required for neurite outgrowth. This was further supported by the fact that blocking Gβγ-MT
interaction by a Gβγ-sequestering peptide, GRK2i, inhibited neurite outgrowth and induced
neurodegeneration (Sierra Fonseca et. al., Manuscript in preparation). The observation that 4-NP
alters MT organization and its association with Gβγ suggests that 4-NP induces
neurodegeneration by affecting the Gβγ-MT mediated pathway.
Proteomic analysis of cytoskeletal fraction (CSK) of 4-NP-treated PC12 cells (both
control PC12 and NGF-differentiated cells) produced many interesting results. Because of the
insoluble nature of CSK fraction, little attempt was made in the past to carry out proteomic
analysis of this cellular structure. However, recently, while this study was in progress, a group of
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investigators claimed to enrich CSK fraction from mouse embryonic fibroblasts for proteomic
analysis (Choi et.al., 2013; Klemke et. al., 2013). Although this analysis indicated that actin
cytoskeleton and focal adhesion-associated proteins were preserved in CSK preparation,
microtubule cytoskeleton was disrupted during the purification steps used by these investigators.
Our result indicates that (Table 1.1–Table 5.1) MTs and other cytoskeletal proteins were
preserved in CSK fraction isolated using our protocol. In addition, heterotrimeric G protein
subunits (β, and γ) were found to be associated with cytoskeletal fractions. This finding supports
the core hypothesis of our laboratory research—that Gβγ is an integral component of cell
cytoskeleton. The result also suggests that NGF-induced neuronal differentiation involves up- or
down-regulation of these proteins. Proteomic analysis as well as western blotting reveals that 4NP up-regulated tubulin expression significantly (Table 4.1, Figure 11.1 and 12.1). The result
initially appeared surprising. However, careful analysis of the data and the existing literature I
derived a logical explanation of this data. It has been shown earlier that tubulin synthesis in cell
is regulated by an autoregulatory mechanism where level of tubulin monomer/dimer guide the
synthesis of tubulin mRNA expression in cells (Caron and Kirschner., 1986). Therefore, it is
likely that the disruption of MTs observed in the presence of 4-NP altered the tubulin polymermonomer equilibrium in cells, followed by reduced level of tubulin monomer which
subsequently triggered tubulin synthesis. Cartelli et al also observed a significant increase in
neuron-specific βIII tubulin and enrichment of detyr-tubulin in dopaminergic neurons in
experimental parkinsonium induced by MPTP in C51B1 mice (Cartelli et al., 2013)
Although confocal microscopic analysis indicated that 4-NP disrupted MT organization,
biochemical analysis did not show any changes in the level of MT assembly in the presence of 4NP (Fig.10). The result could be explained by the fact that 4-NP did not cause depolymerization
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of MTs, rather induced tubulin aggregation by disrupting MT formation. Since, aggregated
proteins remain in the polymeric form, the net change in polymer-monomer equilibrium was not
altered by 4-NP.
In summary, I have demonstrated that 4-NP at a concentrations as low as 0.2µM (44.07
µg/L) blocked neurite outgrowth and at higher concentration (5-10µM, ~1000-2000µg/L)
induced cellular aggregation and neurodegeneration. Most NP-effect is associated with water
concentration ranging from 1 to 1000µg/L (California Environmental Protection Agency, 2009).
Concentrations of 4-nonylphenol in surface waters are in the range of 0.11 to 180 micrograms
per liter. (Tanghe and Verstraete, 2001). However, this concentration may not reflect 4-NP
exposure in the environment, based on 4-NP’s low solubility and hydrophobicity, and higher
concentrations often detected in Biosolid and sediment samples. Using PC12 cells as a model
system, our study clearly demonstrates the potential risk of 4-NP in affecting neuronal
development and inducing neurodegeneration, and should provide essential information in
accessing environment risk of 4-NP.
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